Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:public_company
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:delistedDate |
2023
|
| gptkbp:focus |
men's health therapeutics
|
| gptkbp:foundedYear |
2003
|
| gptkbp:hasCompany |
Clarus Therapeutics Holdings, Inc.
|
| gptkbp:headquartersLocation |
gptkb:Northbrook,_Illinois,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:product |
JATENZO
|
| gptkbp:status |
delisted
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
CRXT
|
| gptkbp:bfsParent |
gptkb:Clarus_Therapeutics
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
NASDAQ:CRXT
|